Teda Biology (08189.HK) released its interim results, with a net loss attributable to shareholders of 6.4264 million yuan, an increase of 55.86% year-on-year.

The Intelligent Wealth APP reported that TaiDa Bio (08189.HK) released its interim performance for the six months ending June 30, 2025. The group's revenue was 226 million yuan, a year-on-year increase of 7.01%; the net loss attributable to shareholders was 6.4264 million yuan, a year-on-year increase of 55.86%; and the loss per share was 0.317 points.